Myriad Genetics Inc (NASDAQ:MYGN)

During the Trading Day
34.00 +0.41 / +1.22%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
33.68 -0.3172 / -0.93%
 
Volume: 600.00
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Evans James S
Chief Financial Officer
Sale9/23/201475,864$38.08$2.9M-11.33%
Evans James S
Chief Financial Officer
Buy9/23/201475,864$30.12$2.3M-11.33%
Marsh Richard M
Executive Vice President & General Counsel
Sale4/30/201430,000$41.80$1.3M-20.42%
Meldrum Peter D
President & Chief Executive Officer
Sale7/14/201424,000$39.50$948.0K-16.88%
Lanchbury Jerry S
Chief Scientific Officer
Sale7/14/201420,000$39.85$797.0K-16.88%
Evans James S
Chief Financial Officer
Sale9/30/201416,872$38.99$657.8K-12.91%
Evans James S
Chief Financial Officer
Sale9/19/201413,128$37.51$492.4K-10.45%
Marsh Richard M
Executive Vice President & General Counsel
Buy4/30/201430,000$13.28$398.4K-20.42%
Lanchbury Jerry S
Chief Scientific Officer
Buy7/14/201420,000$18.06$361.2K-16.88%
Evans James S
Chief Financial Officer
Sale9/24/20148,790$37.98$333.8K-12.50%
Page of 6

To view my watchlist

Not a member yet?

Sign up now for a free account